Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Revenue

Xilio Therapeutics had revenue of $2.93M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $9.27M. In the year 2024, Xilio Therapeutics had annual revenue of $6.34M.

• Revenue (ttm): $9.27M
• Revenue Growth: n/a
• P/S Ratio: 4.85
• Revenue / Employee: $144,906
• Employees: 64
• Market Cap: 35.73M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.34M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.